Topic
diabetes-drug-development
1 stories related to this topic, newest first.
rediff.comscience60 days ago
Experimental Quintuple Agonist Outperforms Semaglutide in Mouse Obesity Models
A quintuple agonist developed by researchers at Helmholtz Munich combines GLP-1, GIP and PPAR activity to target five receptor systems. The compound reduced body weight, fat mass and blood sugar more effectively than existing therapies in several mouse models. Scientists caution…